Goldman Sachs’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,006
| Closed | -$4.03K | – | 5157 |
|
|
2025
Q1 | $4.03K | Sell |
13,006
-2,985
| -19% | -$924 | ﹤0.01% | 5028 |
|
|
2024
Q4 | $12K | Buy |
+15,991
| New | +$12K | ﹤0.01% | 4938 |
|
|
2022
Q1 | – | Sell |
-85,488
| Closed | -$763K | – | 5763 |
|
|
2021
Q4 | $763K | Buy |
85,488
+34,669
| +68% | +$309K | ﹤0.01% | 4234 |
|
|
2021
Q3 | $494K | Buy |
50,819
+21,916
| +76% | +$213K | ﹤0.01% | 4389 |
|
|
2021
Q2 | $238K | Buy |
28,903
+17,516
| +154% | +$144K | ﹤0.01% | 4831 |
|
|
2021
Q1 | $109K | Buy |
+11,387
| New | +$109K | ﹤0.01% | 5013 |
|
|
2020
Q4 | – | Sell |
-46,971
| Closed | -$638K | – | 4655 |
|
|
2020
Q3 | $638K | Buy |
46,971
+11,345
| +32% | +$154K | ﹤0.01% | 3545 |
|
|
2020
Q2 | $689K | Buy |
35,626
+5,204
| +17% | +$101K | ﹤0.01% | 3438 |
|
|
2020
Q1 | $232K | Buy |
+30,422
| New | +$232K | ﹤0.01% | 3878 |
|